A Study of NHL907 in Healthy Adult Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy Adult Participants

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CMAX Clinical Research Pty Ltd, Adelaide, South Australia, Australia
Contact: Study coordinator (James Connell, MD) · cmax@cmax.com.au · +61 (0)8 7088 7900

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease

Healthy Adult Participants · Diabetic Kidney Disease

Abroad (travel likely)RecruitingPHASE1

Melbourne, Australia

A Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants

Healthy

Abroad (travel likely)RecruitingPHASE1

Seoul, South Korea

Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration

Healthy · Active Non-segmental Vitiligo · Severe Alopecia Areata

Abroad (travel likely)RecruitingPHASE1

Shanghai, China